34545-20-5

Basic information

• Product Name: 3-BROMO-4-METHYL-5-NITROBENZOIC ACID
• Synonyms: Benzoic acid, 3-broMo-4-Methyl-5-nitro-
• CAS NO: 34545-20-5
• Molecular Formula: C₈H₆BrNO₄
• Molecular Weight: 260.04154
• Mol File: 34545-20-5.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 387°C at 760 mmHg
• Flash Point: 187.9°C
• Appearance: /
• Density: 1.777g/cm³
• Vapor Pressure: 1.11E-06mmHg at 25°C
• Refractive Index: 1.633
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 3-BROMO-4-METHYL-5-NITROBENZOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 3-BROMO-4-METHYL-5-NITROBENZOIC ACID(34545-20-5)
• EPA Substance Registry System: 3-BROMO-4-METHYL-5-NITROBENZOIC ACID(34545-20-5)

Safety Data

• Hazardous Substances Data: 34545-20-5(Hazardous Substances Data)

Usage

General Description

3-Bromo-4-methyl-5-nitrobenzoic acid is a chemical compound with the molecular formula C8H6BrNO4. It is a yellow powder that is primarily used as a building block in organic synthesis and in pharmaceutical research. 3-Bromo-4-methyl-5-nitrobenzoic acid is known for its strong and stable nitro group, and it is used as a reagent in the preparation of various pharmaceutical compounds. Additionally, it has been studied for its potential applications in the development of new drugs and materials. 3-Bromo-4-methyl-5-nitrobenzoic acid is a versatile compound with important uses in the field of chemistry and pharmaceuticals.

InChI:InChI=1/C8H6BrNO4/c1-4-6(9)2-5(8(11)12)3-7(4)10(13)14/h2-3H,1H3,(H,11,12)

Upstream product

• 54591-62-7 3-amino-4-methyl-5-nitrobenzoic acid 
• 16533-71-4 3,5-dinitro-p-toluic acid 
• 96-98-0 4-methyl-3-nitrobenzoic acid 

Downstream Products

• 223519-11-7 methyl 3-amino-5-bromo-4-methylbenzoate 
• 1527007-77-7 methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole-6-carboxylate 
• 170487-40-8 1H-indazole-6-carboxylic acid methyl ester 
• 885518-53-6 4-bromo-1H-indazol-6-amine 
• 1638772-21-0 methyl 4-bromo-2-methyl-2H-indazole-6-carboxylate 
• 1638759-79-1 methyl 4-bromo-1-methyl-1H-indazole-6-carboxylate 
• 885523-43-3 4-bromo-1H-indazole-6-carboxylic acid 
• 885518-47-8 methyl 4-bromo-1H-indazole-6-carboxylate 
• 1285531-68-1 1-(4-(6-(N-(2-(piperidin-1-yl)ethyl)aminocarbonyl)-1H-indazol-4-yl)phenyl)-3-(3-(trifluoromethoxy)phenyl)urea 
• 1285532-20-8 C₂₁H₂₅N₅O 
• 223519-08-2 methyl 3-bromo-4-methyl-5-nitrobenzoate 
• 356082-44-5 2-bromo-6-nitroterephthalic acid 
• 72623-43-9 trans-3-bromo-6'-iodo-3'-methoxy-2',4-dimethyl-5-nitrostilbene 

Relevant articles and documents

SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE

The present invention provides compounds of Formula (I) or a subgeneric structure or species thereof, or a pharmaceutically acceptable salt, ester, solvate, and/or prodrug thereof, and methods and compositions for treating or ameliorating abnormal cell pr

Synthesis of substituted 4-(1H-indol-6-yl)-1H-indazoles as potential PDK1 inhibitors

The development of a preparative route to a series of novel 4-(1H-indol-6-yl)-1H-indazole compounds as potential PDK1 inhibitors is described. The synthetic strategy centres on the late-stage Suzuki cross-coupling of N-unprotected indazole and indole frag

PROLYL HYDROXYLASE INHIBITORS

The invention described herein relates to certain 2,4-dioxo-l,2,3,4-tetrahydro-7- quinazolinecarboxamide derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.